Cerity Partners LLC Blueprint Medicines Corp Transaction History

Cerity Partners LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$73.17 - $99.79 $210,510 - $287,095	2,877 New	2,877 $272,000
Q1 2022 Apr 25, 2022	SELL	$54.1 - $110.08 $123,889 - $252,083	-2,290 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$94.25 - $115.99 $8,859 - $10,903	94 Added 4.28%	2,290 $245,000
Q3 2021 Oct 25, 2021	BUY	$80.98 - $109.47 $177,832 - $240,396	2,196 New	2,196 $226,000
Q2 2021 Aug 11, 2021	SELL	$82.78 - $101.0 $177,977 - $217,150	-2,150 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$92.08 - $124.48 $197,972 - $267,632	2,150 New	2,150 $241,000

351

60.3M

2.25M

1.18M

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $5.47B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

Get notified when there are updates to the investment portfolio of Cerity Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Cerity Partners LLC with notifications on news.